
    
      Observe safety and efficacy of human menopausal gonadotropin and human chorionic gonadotropin
      treating congenital hypogonadotropic hypogonadism in teenagers; which as clinic
      recommendation, may provide clinical basis for establishing standard treatment guideline in
      the future. Establish technological process and follow-up precept for human menopausal
      gonadotropin and human chorionic gonadotropin injection treating congenital hypogonadotropic
      hypogonadism in teenagers. And find safety and effective dose for teenagers.
    
  